Specialists for ALK-positive large B-cell lymphoma
8 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing data- Matthew Frigault, MDRare Disease SpecialistMassachusetts General HospitalBoston, MassachusettsQC-verified PI×2
- Stephen M Ansell, M.DRare Disease / Clinical ResearchDana-Farber - Harvard Cancer Center LAOROCHESTER, MNPI×1 5
- Premal Lulla, MD, M.DRare Disease / Clinical ResearchBaylor College of MedicineHOUSTON, TXPI×4
- Stephen M. Ansell, MD, PhD, M.DRare Disease / Clinical ResearchMayo Clinic in RochesterROCHESTER, MNPI×2
- Claire Tiger, MD, PhD, M.DRare Disease / Clinical ResearchMayo ClinicROCHESTER, MNPI×1
- Frank G Basile, M.D., MDRare Disease / Clinical ResearchSchrodinger Inc.RIVERSIDE, RIPI×1
- Ryan LynchRare Disease / Clinical ResearchFred Hutch/University of Washington Cancer ConsortiumPI×4 8
- Chet Bohac, PharmD, MD, MScRare Disease / Clinical ResearchExecutive Medical Director, Clinical Development, Xencor, Inc.PI×1